To be added to Trxade Health’s investor lists, please contact Todd Markey at Investor Relations Partners at 81 or via email at Investor Relations Partners, Inc. We believe Trxade Health should be of particular interest to value and earnings growth investors given our belief that the company is significantly undervalued when considering the vast potential of its proprietary disruptive technology and its outlook for accelerated growth and profitability,” concluded Mr. Todd Markey, Vice President of Investor Relations Partners, said, “We are looking forward to communicating Trxade Health’s investment story to beyond its existing shareholder base and the health care sector. Based on our current double-digit revenue growth rates and increasing demand for our services, we expect 2016 to be a profitable and breakthrough year for Trxade and its shareholders and look forward to updating the market on our progress as we continue to execute on our business plan,” concluded Mr.
“We have a number of exciting developments at Trxade Health driven by our proprietary technology that is designed to disrupt the multi-billion dollar pharmaceutical marketplace. “This is an exciting time for Trxade Health and we believe with the help of Investor Relations Partners we will be able to more broadly and effectively communicate our story to the investment community,” said Suren Ajjarapu, Chairman and CEO of Trxade Health. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, today announced that it has retained Investor Relations Partners (IRP) to expand the Company’s strategic investor relations program. 29, 2015 (GLOBE NEWSWIRE) - Trxade Health, Inc. Trxade Health featured on NASDAQ tower on in Times Square NY.
0 kommentar(er)
